New leadership at Seattle-area companies including Starbucks, Avanade, Tune Therapeutics, Umoja Biopharma, Siteimprove and ...
Leading epigenome company Tune Therapeutics is proud to announce that veteran drug-development executive John McHutchison AO, ...
John McHutchison started Monday as CEO and chairman of Tune Therapeutics, after sitting on the company’s board for two years.
Hosted on MSN1mon
Fast-moving Durham startup Tune Therapeutics works to turn off genes that cause diseasesLaunched from a Duke University lab four years ago, the biotech startup Tune Therapeutics announced a major milestone Sunday — raising $175 million in a Series B funding round to support its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results